MSEPX
Price
$23.18
Change
-$0.09 (-0.39%)
Updated
Jul 25 closing price
Net Assets
563.82M
RNWBX
Price
$85.67
Change
-$0.40 (-0.46%)
Updated
Jul 25 closing price
Net Assets
70.79B
Interact to see
Advertisement

MSEPX vs RNWBX

Header iconMSEPX vs RNWBX Comparison
Open Charts MSEPX vs RNWBXBanner chart's image
Morgan Stanley Inst Emerging Mkts C
Price$23.18
Change-$0.09 (-0.39%)
VolumeN/A
Net Assets563.82M
American Funds New World R2
Price$85.67
Change-$0.40 (-0.46%)
VolumeN/A
Net Assets70.79B
MSEPX vs RNWBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MSEPX vs. RNWBX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEPX is a StrongBuy and RNWBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 70.8B vs. MSEPX (564M). MSEPX pays higher dividends than RNWBX: MSEPX (0.17) vs RNWBX (0.13). MSEPX was incepted earlier than RNWBX: MSEPX (10 years) vs RNWBX (23 years). MSEPX (3.13) is less costly to investors than RNWBX (1.67). MSEPX is a more actively managed with annual turnover of: 41.00 vs. RNWBX (37.00). RNWBX has a lower initial minimum investment than MSEPX: RNWBX (250) vs MSEPX (1000). MSEPX (15.08) and RNWBX (14.84) have marching annual gain over last year. RNWBX return over 5 years is better than : 24.82 vs. MSEPX (11.30).
MSEPXRNWBXMSEPX / RNWBX
Total Expense Ratio2.101.67126%
Annual Report Gross Expense Ratio3.131.67187%
Fund Existence10 years23 years-
Gain YTD16.01616.47997%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets564M70.8B1%
Annual Yield % from dividends0.170.13131%
Returns for 1 year15.0814.84102%
Returns for 3 years34.6637.5292%
Returns for 5 years11.3024.8246%
Returns for 10 years11.0966.5417%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLPG32.651.80
+5.83%
Galapagos NV
VATE5.810.11
+1.93%
INNOVATE Corp
RDZN1.24N/A
N/A
Roadzen
HSIC71.46-1.16
-1.60%
Henry Schein
TNFA0.12-0.02
-11.52%
TNF Pharmaceuticals Inc.